Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -28.88% of over the last 5 years
The company has declared negative results for the last 11 consecutive quarters
With ROCE of 1.8, it has a Expensive valuation with a 1.6 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 700 Cr (Micro Cap)
NA (Loss Making)
44
0.27%
0.29
0.82%
1.67
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 Jul 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 04 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Chemfab Alkalis Ltd Valuation Shifts to Very Expensive Amid Mixed Returns
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. Despite a modest day change of 0.05% and a current price of ₹395.00, the company’s price-to-earnings (P/E) ratio and other valuation metrics reveal a complex picture that investors must carefully analyse amid mixed returns and sector dynamics.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Board Meeting Intimation for Approval Of The Audited Financial Statements For The Quarter And Year Ended 31St March 2026 And To Consider Declaration Of Dividend If Any.
07-May-2026 | Source : BSEChemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday 13th May 2026 at 2:00 PM (IST) to consider and approve inter-alia the following businesses: - i) Audited Standalone and Consolidated Financial Statements for the Quarter and Year Ended 31st March 2026. ii) To Consider declaration of Dividend subject to the approval of Shareholders if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the closure of trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a period of 48 hours from the dissemination of results with the Stock Exchanges. Request you to kindly take the same on record as required under the provisions of the above captioned Regulation.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Apr-2026 | Source : BSESubmission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 31st March 2026
Closure of Trading Window
25-Mar-2026 | Source : BSESubmission of Letter for intimating the closure of trading window period w.e.f. 1st April 2026 till the expiry of 48 hours after the announcement of the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2026.
Corporate Actions 
13 May 2026
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.63%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






